Eniluracil: Phase I preliminary data

In an open-label, dose-escalation, U.S. Phase I trial in 13 evaluable patients,

Read the full 125 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE